LHRH antagonist
Uemura, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 568-572
2016
ISSN/ISBN: 0047-1852 PMID: 27344795 Document Number: 689000
Document emailed within 1 workday
Related Documents
Keizman, D.; Eisenberger, M.A. 2009: LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy? Oncology 23(7): 631-632Okuda, K.; Ushiroyama, T.; Yoshikawa, M.; Sugimoto, O. 1988: Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH Nihon Sanka Fujinka Gakkai Zasshi 40(12): 1889-1893
Arimura, A.; Talbot, S.; Serafini, P.C.; Schally, A.V. 1980: Sites of paradoxical action of the LHRH agonist (D-Trp6)-LHRH International Journal of Fertility 25(3): 151-156
Zhu, B.; Chu, Y.; Chu, J.; Liu, Y. 1990: The direct effects of lhrh and three lhrh analogs on progesterone secretion by early pregnant human luteal cells in vitro Journal of Shanghai Medical University 17(1): 11-14
Wanderley, M.I.; Negro-Vilar, A. 1996: Pretreatment with phorbol ester and an LHRH agonist reduces testosterone production and protein kinase C activity in rat Leydig cells challenged with PDBu and LHRH Brazilian Journal of Medical and Biological Research 29(11): 1557-1565
Singh, V. 1992: Immunospecificity and affinity studies on anti-luteinizing hormone releasing hormone antibodies developed by azo-LHRH-TT and azo-LHRH-BSA conjugates Biochemistry International 27(4): 591-599
Dondi, D.; Limonta, P.; Moretti, R.M.; Marelli, M.M.; Garattini, E.; Motta, M. 1994: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop Cancer Research 54(15): 4091-4095
Ennis, C.; Cox, B. 1980: The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors Journal of Pharmacy and Pharmacology 32(6): 434-435
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913
Baranowska, B. 1984: Clinical use of LHRH analogs Polski Tygodnik Lekarski 39(29-30): 1005-1007
Guoth, J.; Zsolnai, B. 1986: LHRH treatment of hypothalamic amenorrhoea Acta Medica Hungarica 43(2): 223-228
Smals, A.G. 1985: Clinical significance of LHRH and its analogs Nederlands Tijdschrift Voor Geneeskunde 129(1): 15-20
Nillius, S.J. 1984: Lhrh nasal spray in contraception Contraceptive Delivery Systems 5(3)
Sandow, J. 1983: Clinical applications of LHRH and its analogues Clinical Endocrinology 18(6): 571-592
Kumasaka, T.; Masaoka, K.; Watanabe, H.; Mori, T.; Ohya, H.; Tadokoro, N. 1986: Neuroendocrine regulation of LHRH and gonadotropin Advances in Contraceptive Delivery Systems: Cds 2(2-3): 176-181
Balmaceda, J.P.; Borrero, C.; Asch, R.H. 1987: Lhrh analogs female contraception Seminars in Reproductive Endocrinology 5(4): 371-380
Olsson, J.O. 1990: Orchiectomy or LHRH analogues in prostatic cancer? Lakartidningen 87(4): 190
Leung, P.C.; Wang, J. 1989: Inositol lipids and LHRH action in the rat ovary Journal of Reproduction and Fertility. Supplement 37: 287-293
Kimura, K.; Iwamoto, M.; Tanaka, S.; Watanabe, T.; Aihara, T.; Sugimoto, T.; Miyara, K.; Hayashi, M.; Kouno, T.; Baba, S.; Kawashima, H.; Hashimoto, N.; Uchiyama, K. 2015: Is the LHRH Agonist Recommended for Fertility Preservation ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 1019-1021
Rubio Herrera, M.A.; Calle Fernández, J.R. 1986: Treatment of carcinoma of the prostate with analogs of LHRH Revista Clinica Espanola 179(8): 407-411